Onconetix (ONCO) Net Margin (2023 - 2025)
Historic Net Margin for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to 2892.7%.
- Onconetix's Net Margin fell 19519800.0% to 2892.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 4154.88%, marking a year-over-year decrease of 9765500.0%. This contributed to the annual value of 2333.39% for FY2024, which is 616530900.0% up from last year.
- Latest data reveals that Onconetix reported Net Margin of 2892.7% as of Q3 2025, which was down 19519800.0% from 2536.24% recorded in Q2 2025.
- In the past 5 years, Onconetix's Net Margin ranged from a high of 11855.21% in Q4 2023 and a low of 9560.15% during Q1 2025
- Moreover, its 3-year median value for Net Margin was 1808.57% (2024), whereas its average is 666.04%.
- Per our database at Business Quant, Onconetix's Net Margin plummeted by -160189400bps in 2024 and then crashed by -5064900bps in 2025.
- Quarter analysis of 3 years shows Onconetix's Net Margin stood at 11855.21% in 2023, then crashed by -135bps to 4163.73% in 2024, then skyrocketed by 31bps to 2892.7% in 2025.
- Its Net Margin stands at 2892.7% for Q3 2025, versus 2536.24% for Q2 2025 and 9560.15% for Q1 2025.